𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjects

✍ Scribed by S. KANG; K.H. KIM; Y.T. KIM; Y.T. KIM; J.H. KIM; Y.S. SONG; S.H. SHIN; H.S. RYU; J.W. HAN; J.H. KANG; S.Y. PARK

Book ID
109086326
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
120 KB
Volume
18
Category
Article
ISSN
1048-891X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, immunogenicity, and efficacy of
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women
✍ Gonzalo Perez; Eduardo Lazcano-Ponce; Mauricio Hernandez-Avila; Patricia J. Garc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 103 KB

## Abstract The prevalence of HPV infection in Latin America is among the highest in the world. A quadrivalent (types 6/11/16/18) human papillomavirus L1 virus‐like‐particle vaccine has been shown to be 95–100% effective in preventing HPV 6/11/16/18‐related cervical and genital disease in women naï